[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69024744D1 - Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten - Google Patents

Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten

Info

Publication number
DE69024744D1
DE69024744D1 DE69024744T DE69024744T DE69024744D1 DE 69024744 D1 DE69024744 D1 DE 69024744D1 DE 69024744 T DE69024744 T DE 69024744T DE 69024744 T DE69024744 T DE 69024744T DE 69024744 D1 DE69024744 D1 DE 69024744D1
Authority
DE
Germany
Prior art keywords
treatment
ketoprostaglandin
disease
hepatobilary
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69024744T
Other languages
English (en)
Other versions
DE69024744T2 (de
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69024744D1 publication Critical patent/DE69024744D1/de
Application granted granted Critical
Publication of DE69024744T2 publication Critical patent/DE69024744T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69024744T 1989-10-20 1990-10-18 Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten Expired - Lifetime DE69024744T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27460689 1989-10-20

Publications (2)

Publication Number Publication Date
DE69024744D1 true DE69024744D1 (de) 1996-02-22
DE69024744T2 DE69024744T2 (de) 1996-05-23

Family

ID=17544076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024744T Expired - Lifetime DE69024744T2 (de) 1989-10-20 1990-10-18 Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten

Country Status (10)

Country Link
US (1) US5096927A (de)
EP (1) EP0424156B1 (de)
JP (1) JPH03204816A (de)
KR (1) KR0127297B1 (de)
AT (1) ATE132749T1 (de)
CA (1) CA2027814C (de)
DE (1) DE69024744T2 (de)
DK (1) DK0424156T3 (de)
ES (1) ES2085898T3 (de)
GR (1) GR3018674T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2041417C (en) * 1990-05-01 2002-05-21 Ryuji Ueno Treatment of pancreatic disease with 15-keto-prostaglandin compounds
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
KR100681221B1 (ko) * 1997-10-13 2007-02-09 가부시키가이샤 아루떼꾸 우에노 문맥압 상승 억제제
DE69839767D1 (de) * 1997-11-28 2008-09-04 Sucampo Ag Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
AU4472701A (en) * 2000-04-06 2001-10-23 Sucampo Ag Bile secretion promoting composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
WO2008108322A2 (en) * 2007-02-27 2008-09-12 Sucampo Ag Composition and method for protecting mitochondria
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374856A (en) * 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
FR2517679A1 (fr) * 1981-12-03 1983-06-10 Synthelabo Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
JPS62277352A (ja) * 1986-01-30 1987-12-02 Ono Pharmaceut Co Ltd 新規な6−ケト−プロスタグランジンe1誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
DE3873007T2 (de) * 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤

Also Published As

Publication number Publication date
GR3018674T3 (en) 1996-04-30
EP0424156A3 (en) 1992-04-22
ES2085898T3 (es) 1996-06-16
US5096927A (en) 1992-03-17
EP0424156B1 (de) 1996-01-10
KR910007531A (ko) 1991-05-30
JPH03204816A (ja) 1991-09-06
DE69024744T2 (de) 1996-05-23
ATE132749T1 (de) 1996-01-15
JPH0571568B2 (de) 1993-10-07
CA2027814C (en) 1996-07-30
CA2027814A1 (en) 1991-04-21
EP0424156A2 (de) 1991-04-24
DK0424156T3 (da) 1996-02-05
KR0127297B1 (ko) 1998-04-01

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
NO912745D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH